<!DOCTYPE html>
<html lang="en-us">
<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="theme" content="hugo-academic">
  <meta name="generator" content="Hugo 0.25.1" />
  <meta name="author" content="Mark Coster">
  <meta name="description" content="Associate Professor of Organic and Medicinal Chemistry">

  
  
  
    
  
  
    
    
    <link rel="stylesheet" href="/css/highlight.min.css">
    
  
  
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.7/css/bootstrap.min.css" integrity="sha512-6MXa8B6uaO18Hid6blRMetEIoPqHf7Ux1tnyIQdpt9qI5OACx7C+O3IVTr98vwGnlcg0LOLa02i9Y1HpVhlfiw==" crossorigin="anonymous">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.0/css/academicons.min.css" integrity="sha512-GGGNUPDhnG8LEAEDsjqYIQns+Gu8RBs4j5XGlxl7UfRaZBhCCm5jenJkeJL8uPuOXGqgl8/H1gjlWQDRjd3cUQ==" crossorigin="anonymous">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css" integrity="sha512-SfTiTlX6kk+qitfevl/7LibUOeJWlt9rbyDn92a1DqWOw9vWG2MFoays0sgObmWazO5BQPiFucnnEAjpAB+/Sw==" crossorigin="anonymous">
  
  
  <link rel="stylesheet" href="//fonts.googleapis.com/css?family=Lato:400,700%7CMerriweather%7CRoboto+Mono">
  <link rel="stylesheet" href="/css/hugo-academic.css">
  

  

  <link rel="alternate" href="https://mcoster.github.io/index.xml" type="application/rss+xml" title="Mark Coster">
  <link rel="feed" href="https://mcoster.github.io/index.xml" type="application/rss+xml" title="Mark Coster">

  <link rel="icon" type="image/png" href="/img/icon.png">
  <link rel="apple-touch-icon" type="image/png" href="/img/apple-touch-icon.png">

  <link rel="canonical" href="https://mcoster.github.io/">

  

  <title>Mark Coster</title>

</head>
<body id="top" data-spy="scroll" data-target="#navbar-main" data-offset="71">

<nav class="navbar navbar-default navbar-fixed-top" id="navbar-main">
  <div class="container">

    
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse"
              data-target=".navbar-collapse" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="/">Mark Coster</a>
    </div>

    
    <div class="collapse navbar-collapse">

      
      <ul class="nav navbar-nav navbar-right">
        

        

        <li class="nav-item">
          <a href="/#about" data-target="#about">
            
            <span>Home</span>
          </a>
        </li>

        
        

        

        <li class="nav-item">
          <a href="/#publications_selected" data-target="#publications_selected">
            
            <span>Publications</span>
          </a>
        </li>

        
        

        

        <li class="nav-item">
          <a href="/#posts" data-target="#posts">
            
            <span>Posts</span>
          </a>
        </li>

        
        

        

        <li class="nav-item">
          <a href="/#projects" data-target="#projects">
            
            <span>Projects</span>
          </a>
        </li>

        
        

        

        <li class="nav-item">
          <a href="/#teaching" data-target="#teaching">
            
            <span>Teaching</span>
          </a>
        </li>

        
        

        

        <li class="nav-item">
          <a href="/#contact" data-target="#contact">
            
            <span>Contact</span>
          </a>
        </li>

        
        

        
      </ul>

    </div>
  </div>
</nav>



<span id="homepage" style="display: none"></span>



  
  
  <section id="about" class="home-section">
    <div class="container">
      



<div class="row" itemprop="author" itemscope itemtype="http://schema.org/Person" itemref="person-email person-telephone person-address">
  <div class="col-xs-12 col-md-4">
    <div id="profile">

      
      <div class="portrait" style="background-image: url('https://mcoster.github.io/img/portrait.jpg');"></div>
      <meta itemprop="image" content="https://mcoster.github.io/img/portrait.jpg">
      

      <div class="portrait-title">
        <h2 itemprop="name">Mark Coster</h2>
        <h3 itemprop="jobTitle">Associate Professor of Organic and Medicinal Chemistry</h3>
        
        <h3 itemprop="worksFor" itemscope itemtype="http://schema.org/Organization">
          <a href="https://www.griffith.edu.au" target="_blank" itemprop="url">
            <span itemprop="name">Griffith University</span>
          </a>
        </h3>
        
      </div>

      <link itemprop="url" href="https://mcoster.github.io/">

      <ul class="social-icon" aria-hidden="true">
        
        
        <li>
          <a itemprop="sameAs" href="mailto:m.coster@griffith.edu.au" target="_blank">
            <i class="fa fa-envelope big-icon"></i>
          </a>
        </li>
        
        
        <li>
          <a itemprop="sameAs" href="https://twitter.com/MarkCoster_Chem" target="_blank">
            <i class="fa fa-twitter big-icon"></i>
          </a>
        </li>
        
        
        <li>
          <a itemprop="sameAs" href="https://www.linkedin.com/in/mark-coster-53b05457/" target="_blank">
            <i class="fa fa-linkedin big-icon"></i>
          </a>
        </li>
        
        
        <li>
          <a itemprop="sameAs" href="https://scholar.google.com.au/citations?hl=en&amp;user=VsqcuYkAAAAJ&amp;view_op=list_works&amp;citft=1&amp;citft=2&amp;email_for_op=m.coster%40griffith.edu.au&amp;gmla=AJsN-F62Khf_Uzw6EqlD6XNYbB_f9i5uUiaK-qWf_67ogbFAa0Lekg8bJ-6aquZuxk_HtvqYDOpWpuK7flAmb9gAyJx6ZfoD3sQ9A9XFH0SYAVTqY0cEy5FAry_RNxIDUpu7eYUms7jfFPwRzTogGpZD8C_Yke3PrMwpSQwIwA82IaAM_tNlOeyND-mHdBqC0kZFC8upzKbWW70BX4oDcLulByQx4cBc6dU61zezV6EfYm9wEi3_uaj756XXfLsPWbwbtpe9yKdx" target="_blank">
            <i class="ai ai-google-scholar big-icon"></i>
          </a>
        </li>
        
        
        <li>
          <a itemprop="sameAs" href="https://github.com/mcoster" target="_blank">
            <i class="fa fa-github big-icon"></i>
          </a>
        </li>
        
      </ul>

    </div>
  </div>
  <div class="col-xs-12 col-md-8" itemprop="description">

    

<h1 id="biography">Biography</h1>

<p>Mark Coster is an Associate Professor of organic and medicinal chemistry at the Griffith Institute for Drug Discovery, Griffith University. His research interests include the development of new methods in organic synthesis, synthesis of bioactive natural products and medicinal chemistry. He leads the Bioactive Molecule Synthesis group, who develop new strategies for the synthesis of 3D, stereochemically rich compounds for drug discovery, synthesise new anti-malarial and anticancer compounds and, with collaborators, explore their mechanisms of action.</p>


    <div class="row">

      
      <div class="col-sm-5">
        <h3>Interests</h3>
        <ul class="ul-interests">
          
          <li>Organic Chemistry</li>
          
          <li>Medicinal Chemistry</li>
          
          <li>Drug Discovery</li>
          
        </ul>
      </div>
      

      
      <div class="col-sm-7">
        <h3>Education</h3>
        <ul class="ul-edu fa-ul">
          
          <li>
            <i class="fa-li fa fa-graduation-cap"></i>
            <div class="description">
              <p class="course">PhD in Organic Chemistry, 2001</p>
              <p class="institution">University of Cambridge</p>
            </div>
          </li>
          
          <li>
            <i class="fa-li fa fa-graduation-cap"></i>
            <div class="description">
              <p class="course">BSc(Hons) 1st class, 1996</p>
              <p class="institution">University of Queensland</p>
            </div>
          </li>
          
          <li>
            <i class="fa-li fa fa-graduation-cap"></i>
            <div class="description">
              <p class="course">BSc, 1995</p>
              <p class="institution">University of Queensland</p>
            </div>
          </li>
          
        </ul>
      </div>
      

    </div>
  </div>
</div>

    </div>
  </section>

  
  
  <section id="publications_selected" class="home-section">
    <div class="container">
      



<div class="row">
  <div class="col-xs-12 col-md-4 section-heading">
    <h1>Selected Publications</h1>
    
  </div>
  <div class="col-xs-12 col-md-8">
    

    
    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/lepage2017/" itemprop="url">A bidirectional synthesis of spiroacetals via Rh(II)-catalysed C-H insertion.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        Acyclic methylene acetals bearing two diazoester subunits were converted to [5,5]-spiroacetals via bidirectional C-H insertion under Rh(II) catalysis.  Using a chiral Rh(II) catalyst, the major diastereomer was produced in high enantiomeric excess (89%).
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Lepage, Romain J., White, Jonathan M., Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Chemical Communications (Cambridge, United Kingdom) 2017, 53, 4219-4221
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/lepage2017/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/cross2017a/" itemprop="url">Enzyme characteristics of pathogen-specific trehalose-6-phosphate phosphatases</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        Owing to the key role of trehalose in pathogenic organisms, there has recently been growing interest in trehalose metabolism for therapeutic purposes.  Trehalose-6-phosphate phosphatase (TPP) is a pivotal enzyme in the most prominent biosynthesis pathway (OtsAB).  Here, we compare the enzyme characteristics of recombinant TPPs from five important nematode and bacterial pathogens, including three novel members of this protein family.  Analysis of the kinetics of trehalose-6-phosphate hydrolysis reveals that all five enzymes display a burst-like kinetic behaviour which is characterised by a decrease of the enzymatic rate after the pre-steady state.  The observed super-stoichiometric burst amplitudes can be explained by multiple global conformational changes in members of this enzyme family during substrate processing.  In the search for specific TPP inhibitors, the trapping of the complex conformational transitions in TPPs during the catalytic cycle may present a worthwhile strategy to explore.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Cross, Megan, Rajan, Siji, Chekaiban, Janine, Saunders, Jake, Hamilton, Chloe, Coster, Mark J., Hofmann, Andreas, Kim, Jeong-Sun, Gasser, Robin B., Hofmann, Andreas, Hofmann, Andreas
        
      </div>

      <div class="pub-publication">
        
        Scientific reports 2017, 7, 2015
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/cross2017a/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/cross2017/" itemprop="url">Probing function and structure of trehalose-6-phosphate phosphatases from pathogenic organisms suggests distinct molecular groupings.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The trehalose biosynthetic pathway is of great interest for the development of novel therapeutics because trehalose is an essential disaccharide in many pathogens but is neither required nor synthesized in mammalian hosts.  As such, trehalose-6-phosphate phosphatase (TPP), a key enzyme in trehalose biosynthesis, is likely an attractive target for novel chemotherapeutics.  Based on a survey of genomes from a panel of parasitic nematodes and bacterial organisms and by way of a structure-based amino acid sequence alignment, we derive the topol. structure of monoenzyme TPPs and classify them into 3 groups.  Comparison of the functional roles of amino acid residues located in the active site for TPPs belonging to different groups reveal nuanced variations.  Because current literature on this enzyme family shows a tendency to infer functional roles for individual amino acid residues, we investigated the roles of the strictly conserved aspartate tetrad in TPPs of the nematode Brugia malayi by using a conservative mutation approach.  In contrast to aspartate-213, the residue inferred to carry out the nucleophilic attack on the substrate, we found that aspartate-215 and aspartate-428 of BmTPP are involved in the chem. steps of enzymic hydrolysis of the substrate.  Therefore, we suggest that homol.-based inference of functionally important amino acids by sequence comparison for monoenzyme TPPs should only be carried out for each of the 3 groups.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Cross, Megan, Lepage, Romain, Rajan, Siji, Biberacher, Sonja, Young, Neil D., Kim, Bo-Na, Coster, Mark J., Gasser, Robin B., Kim, Jeong-Sun, Hofmann, Andreas.
        
      </div>

      <div class="pub-publication">
        
        FASEB Journal 2017, 31, 920-926,S1-S12
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/cross2017/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/egbewande2017/" itemprop="url">The design, synthesis, and anti-inflammatory evaluation of a drug-like library based on the natural product valerenic acid.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The plant natural product, valerenic acid (1, I) was chosen as a desirable scaffold for the generation of a novel screening library due to its drug-like physicochem. parameters (such as Log P, hydrogen bond donor/acceptor counts, and mol. wt.).  An 11-membered amide library was subsequently generated using parallel soln.-phase synthesis and Ghosez&rsquo;s reagent.  The chem. structures of all semi-synthetic analogs were elucidated following anal. of the NMR, MS, UV and IR data.  The structures of compds. 8 and 11 (VIII and XI, resp.) were also confirmed by X-ray crystallog. anal.  All library members were evaluated for their ability to inhibit the release of IL-8 and TNF-α.  Six analogs showed moderate activity in the IL-8 assay with IC50 values of 2.8-8.3 μM, while none of the tested compds. showed any significant effect on inhibiting TNF-α release.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Egbewande, Folake A., Nilsson, Niclas, White, Jonathan M., Coster, Mark J., Davis, Rohan A.
        
      </div>

      <div class="pub-publication">
        
        Bioorganic &amp; Medicinal Chemistry Letters 2017, 27, 3185-3189
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/egbewande2017/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/sarnpitak2015/" itemprop="url">Panel docking of small-molecule libraries - Prospects to improve efficiency of lead compound discovery.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        Computational docking as a means to prioritise small mols. in drug discovery projects remains a highly popular in silico screening approach.  Contemporary docking approaches without exptl. parametrisation can reliably differentiate active and inactive chemotypes in a protein binding site, but the absence of a correlation between the score of a predicted binding pose and the biol. activity of the mol. presents a clear limitation.  Several novel or improved computational approaches have been developed in the recent past to aid in screening and profiling of small-mol. ligands for drug discovery, but also more broadly in developing conceptual relationships between different protein targets by chem. probing.  Among those new methodologies is a strategy known as inverse virtual screening, which involves the docking of a compd. into different protein structures.  In the present article, we review the different computational screening methodologies that employ docking of at. models, and, by means of a case study, present an approach that expands the inverse virtual screening concept.  By computationally screening a reasonably sized library of 1235 compds. against a panel of 48 mostly human kinases, we have been able to identify five groups of putative lead compds. with substantial diversity when compared to each other.  One representative of each of the five groups was synthesized, and tested in kinase inhibition assays, yielding two compds. with micro-molar inhibition in five human kinases.  This highly economic and cost-effective methodol. holds great promise for drug discovery projects, esp. in cases where a group of target proteins share high structural similarity in their binding sites.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Sarnpitak, Pakornwit, Mujumdar, Prashant, Taylor, Paul, Cross, Megan, Coster, Mark J., Gorse, Alain-Dominique, Krasavin, Mikhail, Hofmann, Andreas.
        
      </div>

      <div class="pub-publication">
        
        Biotechnology Advances 2015, 33, 941-947
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/sarnpitak2015/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/lombard2015/" itemprop="url">Rhodium(II)-catalyzed intramolecular C-H insertion α- to oxygen: reactivity, selectivity and applications to natural product synthesis.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        A review.  The selective functionalization of C-H bonds is a powerful strategy for the construction of org. mols. and the Rh(II)-catalyzed C-H insertion reaction is a particularly robust and useful tool for this purpose.  This review discusses the insertion of Rh(II) carbenes into C-H bonds that are activated by α-oxygen substituents, focusing on the trends that have been obsd. in reactivity and selectivity, and the applications of this reaction to the total synthesis of complex natural products.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Lombard, Fanny J., Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Organic &amp; Biomolecular Chemistry 2015, 13, 6419-6431
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/lombard2015/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/schwartz2015a/" itemprop="url">Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        A series of amide and urea analogs I (R = Me, Et, cyclopropyl, furan-3-yl, Ph, NHBu, NMeOMe ,etc., R1 = H; R = Me, R1 = Me, cyclopentyl, PhCH2, etc.) based on the thiaplakortone A natural product scaffold were synthesized and screened for in vitro antimalarial activity against chloroquine-sensitive (3D7) and chloroquine- and mefloquine-resistant (Dd2) Plasmodium falciparum parasite lines.  Several analogs displayed potent inhibition of P. falciparum growth (IC50 <500 nM) and good selectivity for P. falciparum vs. human neonatal foreskin fibroblast cells (selectivity index >100).  Two of these compds., I (R = Me, NHBu, R1 = H), exhibited good aq. soly. and metabolic stability, and when administered s.c. to mice (32 mg kg-1), plasma concns. remained above 0.2 μM for at least 8 h.  Both I (R = Me, NHBu, R1 = H) were well tolerated in mice after s.c. administration of 32 mg kg-1 twice daily for 4 days.  Using this regimen blood stage P. berghei was suppressed by 52% for I (R = Me, R1 = H) and 26% for I (R = NHBu, R1 = H), relative to the vehicle control.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Schwartz, Brett D., Skinner-Adams, Tina S., Andrews, Katherine T., Coster, Mark J., Edstein, Michael D., MacKenzie, Donna, Charman, Susan A., Koltun, Maria, Blundell, Scott, Campbell, Anna, Pouwer, Rebecca H., Quinn, Ronald J., Beattie, Karren D., Healy, Peter C., Davis, Rohan A.
        
      </div>

      <div class="pub-publication">
        
        Organic &amp; Biomolecular Chemistry 2015, 13, 1558-1570
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/schwartz2015a/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/schwartz2015/" itemprop="url">Synthesis and antiplasmodial evaluation of analogues based on the tricyclic core of Thiaplakortones A-D.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        x regioisomers assocd. with the tricyclic core of thiaplakortones A-D have been synthesized.  Reaction of 1H-indole-4,7-dione and 1-tosyl-1H-indole-4,7-dione with 2-aminoethanesulfinic acid afforded a regioisomeric series, which was subsequently deprotected and oxidized to yield the tricyclic core scaffolds present in the thiaplakortones.  All compds. were fully characterized using NMR and MS data.  A single crystal X-ray structure was obtained on one of the N-tosyl derivs.  All compds. were screened for in vitro antiplasmodial activity against chloroquine-sensitive (3D7) and multidrug-resistant (Dd2) Plasmodium falciparum parasite lines.  Several analogs displayed potent inhibition of P. falciparum growth (IC50 &lt; 500 nM) but only moderate selectivity for P. falciparum vs. human neonatal foreskin fibroblast cells.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Schwartz, Brett D., Coster, Mark J., Skinner-Adams, Tina S., Andrews, Katherine T., White, Jonathan M., Davis, Rohan A.
        
      </div>

      <div class="pub-publication">
        
        Marine Drugs 2015, 13, 5784-5795
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/schwartz2015/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/james2015/" itemprop="url">Synthesis of N-alkylsulfonamides by borane-dimethyl sulfide reduction of N-acylsulfonamides.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        A convenient synthesis of N-alkylsulfonamides in good to excellent yields by redn. of N-acylsulfonamides using BH3·SMe2 is described.  This methodol. presents an attractive alternative for sulfonamide formation.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        James, Samantha N., Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Tetrahedron Letters 2015, 56, 2059-2061
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/james2015/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/pouwer2014/" itemprop="url">Total Synthesis of Thiaplakortone A: Derivatives as Metabolically Stable Leads for the Treatment of Malaria.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        Thiaplakortone A (I), an antimalarial natural product, was prepd. by an operationally simple and scalable synthesis.  In our efforts to deliver a lead compd. with improved potency, metabolic stability, and selectivity, the synthesis was diverted to access a series of analogs.  Several compds. showed nanomolar activity against the chloroquine-sensitive (3D7) Plasmodium falciparum line and were more active against the chloroquine- and mefloquine-resistant (Dd2) P. falciparum line.  All compds. are Rule-of-5 compliant, and we show that metabolic stability can be enhanced via modification at either the primary or pyrrole nitrogen.  These promising results lay the foundation for the development of this structurally unprecedented natural product.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Pouwer, Rebecca H., Deydier, Sophie M., Van Le, Phuc, Schwartz, Brett D., Franken, Nicole C., Davis, Rohan A., Coster, Mark J., Charman, Susan A., Edstein, Michael D., Skinner-Adams, Tina S., Andrews, Katherine T., Jenkins, Ian D., Quinn, Ronald J.
        
      </div>

      <div class="pub-publication">
        
        ACS Medicinal Chemistry Letters 2014, 5, 178-182
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/pouwer2014/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/pigott2014/" itemprop="url">Total synthesis of (±)-nicolaioidesin B via a highly regio- and diastereoselective Diels-Alder reaction.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The total synthesis of rel(2,6-Dihydroxy-4-methoxyphenyl)[(1R,5S,6R)-4-methyl-5-(3-methyl-2-buten-1-yl)-6-phenyl-3-cyclohexen-1-yl]methanone [(±)-nicolaioidesin B] a natural product (flavonoid deriv.) that shows preferential cytotoxicity against pancreatic cancer cells under nutrient starvation conditions, is achieved.  The key step is a thermally-induced, highly regioselective and diastereoselective Diels-Alder reaction between (E)-N-methoxy-N-(methyl)cinnamide and ocimene under solvent-free conditions.  The synthesis of the target compd. was achieved using (1R,5S,6R)-rel-4-methyl-5-(3-methyl-2-buten-1-yl)-6-phenyl-3-cyclohexene-1-carboxaldehyde and 2-bromo-5-methoxy-1,3-bis[[2-(trimethylsilyl)ethoxy]methoxy]benzene as reactants.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Pigott, Adam J., Lepage, Romain J., White, Jonathan M., Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Tetrahedron Letters 2014, 55, 6864-6867
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/pigott2014/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/banwell2012/" itemprop="url">3,4&#39;-Linked bis(piperidines) related to the haliclonacyclamine class of marine alkaloids: synthesis using crossed-aldol chemistry and preliminary biological evaluations.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        Compds. incorporating various elements of the 3,4&rsquo;-bis(piperidine) core assocd. with the sponge-derived alkaloid haliclonacyclamine A (HA), have been prepd. through, inter alia, aldol-type reactions of N-substituted piperidin-4-ones and certain derivs.  Screening of these compds. in various assays, including an ecol. one, reveals that compd. I exhibits allelochem. properties similar to those assocd. with HA itself.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Banwell, Martin G., Coster, Mark J., Hungerford, Natasha L., Garson, Mary J., Su, Stephen, Kotze, Andrew C., Munro, Murray H. G.
        
      </div>

      <div class="pub-publication">
        
        Organic &amp; Biomolecular Chemistry 2012, 10, 154-161
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/banwell2012/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/magolan2012a/" itemprop="url">Synthesis and Evaluation of Anticancer Natural Product Analogues Based on Angelmarin: Targeting the Tolerance towards Nutrient Deprivation.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        A no. od analogs of angelmarin were synthesized and evaluated for their ability to inhibit the tolerance of PANC-1 cells to survive nutrient deprivation.  The most potent of the novel compds. was 8b (I) which possibly acts as a prodrug with improved cell permeability.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Magolan, Jakob, Adams, Nathan B. P., Onozuka, Hiroko, Hungerford, Natasha L., Esumi, Hiroyasu, Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        ChemMedChem 2012, 7, 766-770
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/magolan2012a/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/fischer2011/" itemprop="url">A Concise Route to Dihydrobenzo[b]furans: Formal Total Synthesis of (&#43;)-Lithospermic Acid.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        A sequence of Sonogashira coupling, Pd(II)-catalyzed carbonylative annulation, and benzofuran redn. (Mg, MeOH, NH4Cl) provides a convergent and modular synthetic route to trans-2-aryl-2,3-dihydrobenzo[b]furan-3-carboxylates, which share structural features with numerous biol. active natural products.  This versatile strategy was applied to the formal total synthesis of the anti-HIV natural product (+)-lithospermic acid (I).
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Fischer, Joshua, Savage, G. Paul, Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Organic Letters 2011, 13, 3376-3379
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/fischer2011/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/aumann2011a/" itemprop="url">Arylation of [6,6]-spiroacetal enol ethers: reactivity and rearrangement.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        Attempts to selectively arylate [6,6]-spiroacetal enol ethers at the 2-position delivered unexpected results.  Palladium-mediated arylation conditions afforded the double-Heck product, whereas reaction with benzenesulfinic acid resulted in a facile rearrangement into the corresponding 5-phenylsulfonyl-3,4,5,6-tetrahydrochromans, providing access to 5-aryl-3,4,5,6-tetrahydrochroman and hexahydrochroman derivs.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Aumann, Kylee M., Healy, Peter C., Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Tetrahedron Letters 2011, 52, 1070-1073
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/aumann2011a/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/aumann2011/" itemprop="url">First enantioselective synthesis of methyl (&#43;)-7-methoxyanodendroate, an antitubercular dihydrobenzofuran.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        An enantioselective synthesis of Me (+)-7-methoxyanodendroate was achieved utilizing a Claisen rearrangement, a Grubbs cross-metathesis, and a Shi epoxidn.-cyclization sequence, confirming the abs. configuration assigned to the natural product.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Aumann, Kylee M., Hungerford, Natasha L., Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Tetrahedron Letters 2011, 52, 6988-6990
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/aumann2011/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/dong2011a/" itemprop="url">Mitochondrial Targeting of Vitamin E Succinate Enhances Its Pro-apoptotic and Anti-cancer Activity via Mitochondrial Complex II.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        Mitochondrial complex II (CII) has been recently identified as a novel target for anti-cancer drugs.  Mitochondrially targeted vitamin E succinate (MitoVES) is modified so that it is preferentially localized to mitochondria, greatly enhancing its pro-apoptotic and anti-cancer activity.  Using genetically manipulated cells, MitoVES caused apoptosis and generation of reactive oxygen species (ROS) in CII-proficient malignant cells but not their CII-dysfunctional counterparts.  MitoVES inhibited the succinate dehydrogenase (SDH) activity of CII with IC50 of 80 μM, whereas the electron transfer from CII to CIII was inhibited with IC50 of 1.5 μM.  The agent had no effect either on the enzymic activity of CI or on electron transfer from CI to CIII.  Over 24 h, MitoVES caused stabilization of the oxygen-dependent destruction domain of HIF1α fused to GFP, indicating promotion of the state of pseudohypoxia.  Mol. modeling predicted the succinyl group anchored into the proximal CII ubiquinone (UbQ)-binding site and successively reduced interaction energies for serially shorter phytyl chain homologs of MitoVES correlated with their lower effects on apoptosis induction, ROS generation, and SDH activity.  Mutation of the UbQ-binding Ser68 within the proximal site of the CII SDHC subunit (S68A or S68L) suppressed both ROS generation and apoptosis induction by MitoVES.  In vivo studies indicated that MitoVES also acts by causing pseudohypoxia in the context of tumor suppression.  We propose that mitochondrial targeting of VES with an 11-carbon chain localizes the agent into an ideal position across the interface of the mitochondrial inner membrane and matrix, optimizing its biol. effects as an anti-cancer drug.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Dong, Lan-Feng, Jameson, Victoria J. A., Tilly, David, Cerny, Jiri, Mahdavian, Elahe, Marin-Hernandez, Alvaro, Hernandez-Esquivel, Luz, Rodriguez-Enriquez, Sara, Stursa, Jan, Witting, Paul K., Stantic, Bela, Rohlena, Jakub, Truksa, Jaroslav, Kluckova, Katarina, Dyason, Jeffrey C., Ledvina, Miroslav, Salvatore, Brian A., Moreno-Sanchez, Rafael, Coster, Mark J., Ralph, Stephen J., Smith, Robin A. J., Neuzil, Jiri.
        
      </div>

      <div class="pub-publication">
        
        Journal of Biological Chemistry 2011, 286, 3717-3728
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/dong2011a/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/dong2011/" itemprop="url">Mitochondrial targeting of α-tocopheryl succinate enhances its pro-apoptotic efficacy: A new paradigm for effective cancer therapy.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        Mitochondria are emerging as intriguing targets for anti-cancer agents.  We tested here a novel approach, whereby the mitochondrially targeted delivery of anti-cancer drugs is enhanced by the addn. of a triphenylphosphonium group (TPP+).  A mitochondrially targeted analog of vitamin E succinate (MitoVES), modified by tagging the parental compd. with TPP+, induced considerably more robust apoptosis in cancer cells with a 1-2 log gain in anti-cancer activity compared to the unmodified counterpart, while maintaining selectivity for malignant cells.  This is because MitoVES assocs. with mitochondria and causes fast generation of reactive oxygen species that then trigger mitochondria-dependent apoptosis, involving transcriptional modulation of the Bcl-2 family proteins.  MitoVES proved superior in suppression of exptl. tumors compared to the untargeted analog.  We propose that mitochondrially targeted delivery of anti-cancer agents offers a new paradigm for increasing the efficacy of compds. with anti-cancer activity.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Dong, Lan-Feng, Jameson, Victoria J. A., Tilly, David, Prochazka, Lubomir, Rohlena, Jakub, Valis, Karel, Truksa, Jaroslav, Zobalova, Renata, Mahdavian, Elahe, Kluckova, Katarina, Stantic, Marina, Stursa, Jan, Freeman, Ruth, Witting, Paul K., Norberg, Erik, Goodwin, Jacob, Salvatore, Brian A., Novotna, Jana, Turanek, Jaroslav, Ledvina, Miroslav, Hozak, Pavel, Zhivotovsky, Boris, Coster, Mark J., Ralph, Stephen J., Smith, Robin A. J., Neuzil, Jiri.
        
      </div>

      <div class="pub-publication">
        
        Free Radical Biology &amp; Medicine 2011, 50, 1546-1555
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/dong2011/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/rohlena2011/" itemprop="url">Mitochondrially Targeted α-Tocopheryl Succinate Is Antiangiogenic: Potential Benefit Against Tumor Angiogenesis but Caution Against Wound Healing.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        Aims: A plausible strategy to reduce tumor progress is the inhibition of angiogenesis.  Therefore, agents that efficiently suppress angiogenesis can be used for tumor suppression.  We tested the antiangiogenic potential of a mitochondrially targeted analog of α-tocopheryl succinate (MitoVES), a compd. with high propensity to induce apoptosis.  Results: MitoVES was found to efficiently kill proliferating endothelial cells (ECs) but not contact-arrested ECs or ECs deficient in mitochondrial DNA, and suppressed angiogenesis in vitro by inducing accumulation of reactive oxygen species and induction of apoptosis in proliferating/angiogenic ECs.  Resistance of arrested ECs was ascribed, at least in part, to the lower mitochondrial inner transmembrane potential compared with the proliferating ECs, thus resulting in the lower level of mitochondrial uptake of MitoVES.  Shorter-chain homologs of MitoVES were less efficient in angiogenesis inhibition, thus suggesting a mol. mechanism of its activity.  Finally, MitoVES was found to suppress HER2-pos. breast carcinomas in a transgenic mouse as well as inhibit tumor angiogenesis.  The antiangiogenic efficacy of MitoVES was corroborated by its inhibitory activity on wound healing in vivo.  Innovation and Conclusion: We conclude that MitoVES, a mitochondrially targeted analog of α-tocopheryl succinate, is an efficient antiangiogenic agent of potential clin. relevance, exerting considerably higher activity than its untargeted counterpart.  MitoVES may be helpful against cancer but may compromise wound healing.  Antioxid. Redox Signal. 15, 2923-2935.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Rohlena, Jakub, Dong, Lan-Feng, Kluckova, Katarina, Zobalova, Renata, Goodwin, Jacob, Tilly, David, Stursa, Jan, Pecinova, Alena, Philimonenko, Anatoly, Hozak, Pavel, Banerjee, Jaideep, Ledvina, Miroslav, Sen, Chandan K., Houstek, Josef, Coster, Mark J., Neuzil, Jiri.
        
      </div>

      <div class="pub-publication">
        
        Antioxidants &amp; Redox Signaling 2011, 15, 2923-2935
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/rohlena2011/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/banister2010/" itemprop="url">Oxo-bridged isomers of aza-trishomocubane sigma (σ) receptor ligands: Synthesis, in vitro binding, and molecular modeling.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        Isomeric oxa-bridged analogs of aza-trishomocubane sigma (σ) receptors were synthesized and shown to display a reduced affinity for the σ receptor.  In the case of phenethyl deriv. 4, there was a concomitant introduction of high-affinity for the α2C adrenergic receptor, and moderate affinity for the dopamine transporter.  Mol. modeling was undertaken to rationalize these results.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Banister, Samuel D., Moussa, Iman A., Jordan, Meredith J. T., Coster, Mark J., Kassiou, Michael.
        
      </div>

      <div class="pub-publication">
        
        Bioorganic &amp; Medicinal Chemistry Letters 2010, 20, 145-148
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/banister2010/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/magolan2010/" itemprop="url">Targeting the resistance of pancreatic cancer cells to nutrient deprivation: anti-austerity compounds.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        A review.  The emerging anti-austerity anti-cancer therapeutic strategy targets the ability of certain cancer cell lines, particularly pancreatic cancer, to survive nutrient deprivation.  While biochem. pathways for the tolerance to nutrient deprivation are still not well understood, a growing no. of inhibitors of this process are being discovered.  A no. of natural products have been isolated, structurally characterized and evaluated as inhibitors of austerity, thereby providing valuable initial structure-activity relationship data.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Magolan, Jakob, Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Current Drug Delivery 2010, 7, 355-369
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/magolan2010/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/gunosewoyo2009/" itemprop="url">Purinergic P2X7 receptor antagonists: Chemistry and fundamentals of biological screening.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        A review.  The purinergic P2X7 receptor is a unique member of the ATP-gated P2X family.  This receptor has been implicated in numerous diseases and many structurally diverse ligands have been discovered via high throughput screening.  This perspective will attempt to highlight some of the most recent key findings in both the biol. and chem.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Gunosewoyo, Hendra, Coster, Mark J., Bennett, Maxwell R., Kassiou, Michael.
        
      </div>

      <div class="pub-publication">
        
        Bioorganic &amp; Medicinal Chemistry 2009, 17, 4861-4865
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/gunosewoyo2009/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/magolan2009/" itemprop="url">Total Synthesis of (&#43;)-Angelmarin.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        An efficient 8-step enantioselective total synthesis of (+)-angelmarin (I), starting from com. available umbelliferone, has been achieved.  Key reactions include olefin cross-metathesis and a Shi epoxidn.-cyclization sequence.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Magolan, Jakob, Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Journal of Organic Chemistry 2009, 74, 5083-5086
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/magolan2009/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/gunosewoyo2008/" itemprop="url">Cubyl amides: Novel P2X7 receptor antagonists.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        CH2NHCOR1 [R = 1-adamantanyl, 1-cubyl; R1 = 2-FC6H4, 4-FC6H4, 2,5-Cl(MeO)C6H3] were synthesized and their lipophilicity profiles were evaluated using reverse-phase HPLC.  All synthesized compds. possessed P2X7R antagonistic properties when tested on rat spinal cord microglia cells.  Extensive screening for binding to other neuroceptor subtypes demonstrated their P2X7 selectivity.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Gunosewoyo, Hendra, Guo, Jun Liu, Bennett, Maxwell R., Coster, Mark J., Kassiou, Michael.
        
      </div>

      <div class="pub-publication">
        
        Bioorganic &amp; Medicinal Chemistry Letters 2008, 18, 3720-3723
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/gunosewoyo2008/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/dolle2008/" itemprop="url">Synthesis and In-Vivo Evaluation of [11C]p-PVP-MEMA as a PET Radioligand for Imaging Nicotinic Receptors.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        Within the class of (4-pyridinyl)vinylpyridines developed by Abbott labs. as potent neuronal nicotinic acetylcholine receptor ligands, p-PVP-MEMA ({&reg;-2-[6-chloro-5-((E)-2-pyridin-4-ylvinyl)pyridin-3-yloxy]-1-methylethyl}methylamine) is the lead compd. of a novel series that do not display the traditional nicotinic-like pyrrole-ring but still possessing high subnanomolar affinity (Ki 0.077 nm-displacement of <a href="-" target="_blank">3H</a>cytisine from whole rat brain synaptic membranes).  In the present study, p-PVP-MEMA and its nor-deriv. ({&reg;-2-[6-chloro-5-((E)-2-pyridin-4-ylvinyl)pyridin-3-yloxy]-1-methylethyl}methylamine) as precursor for labeling with the short-lived positron-emitter carbon-11 (T1/2 20.4 min) were synthesized in 10 chem. steps from 2-hydroxy-5-nitropyridine and Boc-D-alanine.  N-Alkylation of nor-p-PVP-MEMA with [11C]methyl iodide afforded [11C]p-PVP-MEMA (&gt;98% radiochem. pure, specific activity of 86.4 GBq μmol-1) in 2% (non-decay cor. and non-optimized) radiochem. yield, in 34 min (including HPLC purifn. and formulation).  Preliminary positron emission tomog. (PET) results obtained in a Papio hamadryas baboon showed that [11C]p-PVP-MEMA is not a suitable PET-radioligand.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Dolle, Frederic, Langle, Sandrine, Roger, Gaelle, Fulton, Roger R., Lagnel-de Bruin, Beatrice, Henderson, David J., Hinnen, Francoise, Paine, Taliesha, Coster, Mark J., Valette, Heric, Bottlaender, Michel, Kassiou, Michael.
        
      </div>

      <div class="pub-publication">
        
        Australian Journal of Chemistry 2008, 61, 438-445
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/dolle2008/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/banister2007/" itemprop="url">(1R,2S,3R,6S,7R,8S)-Tricyclo[6.2.1.02,7]undeca-4,9-diene-3,6-diol.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The asym. unit of (1R,2S,3R,6S,7R,8S)-tricyclo[6.2.1.02,7]undeca-4,9-diene-3,6-diol, C11H14O2, contains 2 mols.  The alc. groups have cis stereochem. and are involved in H bonding (acting as both donors and acceptors), giving an infinite 3-dimensional network.  Crystallog. data are given.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Banister, Samuel D., Clegg, Jack K., Coster, Mark J., Jolliffe, Katrina A., Kassiou, Michael.
        
      </div>

      <div class="pub-publication">
        
        Acta Crystallographica, Section E: Structure Reports Online 2007, 63, o92-o93
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/banister2007/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/cergol2007/" itemprop="url">Asymmetric aldol reaction using boron enolates.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The protocol for the prepn. of boron enolate and its subsequent reaction with aldehyde is described, providing convenient access to β-hydroxy ketone I in good yields and with high stereoselectivities.  The reaction consists of three steps: first, the ketone is rapidly converted to the corresponding boron enolate II, by exposure to a chlorodialkylborane and tertiary amine base, which is then reacted in situ with the aldehyde.  Finally, oxidative workup of the resultant boron aldolate provides aldol adduct.  The reaction procedure requires approx. 28 h to complete over a 2-day period, consisting of 5 h to set up the reaction, whereupon the reaction mixt. is left at -20°C overnight (16 h), followed by 7 h for workup and purifn.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Cergol, Katie M., Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Nature Protocols 2007, 2, 2568-2573
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/cergol2007/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/gunosewoyo2007/" itemprop="url">Molecular probes for P2X7 receptor studies.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        A review.  The ionotropic P2X7 receptor (P2X7R) has become the focus of intense research interest for a no. of reasons:.  (i) It is a cation selective ion channel that is modulated by extracellular ATP.  Upon stimulation by high concns. of ATP it generates a non-selective membrane pore which is permeable to hydrophilic mols. with mol. wt. up to 900 Da.  (ii) Though its physiol. function is yet to be fully understood, there is high P2X7R expression in microglia.  Importantly, this implies a pivotal role for the P2X7R in neuro-inflammatory and -degenerative processes.  In addn., P2X7R-stimulated release of traditional neurotransmitters in the brain, such as glutamate and GABA, further supports the involvement of P2X7R in neuro-inflammatory and -degenerative processes.  P2X7-knockout animals are also found to be resistant to inflammation and neuropathic pain, which suggests that P2X7 antagonists could potentially serve as all-purpose analgesics.  Recent advances in the development of P2X7R ligands have resulted in identification of several different classes of P2X7R antagonists, including ATP analogs (oxidized ATP), dyes (Brilliant Blue G), tyrosine derivs. (KN-62 and KN-04), cyclic imides, adamantane and benzamide derivs.  A KN-62 related radioligand has also recently been reported for use in receptor binding assays.  A more extensive range of potent, selective P2X7R ligands is required for a better understanding of the cascade of cellular processes assocd. with the P2X7R.  This article will review P2X7R ligands discovered to date, together with their biol. activity and therapeutic potential.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Gunosewoyo, Hendra, Coster, Mark J., Kassiou, Michael.
        
      </div>

      <div class="pub-publication">
        
        Current Medicinal Chemistry 2007, 14, 1505-1523
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/gunosewoyo2007/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/cergol2007a/" itemprop="url">Reversibility in the boron-mediated ketone-ketone aldol reaction.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The boron-mediated ketone-ketone aldol reaction is demonstrated, through 1H NMR studies, to be reversible, in contrast to the strictly irreversible aldol reactions of boron enolates with aldehydes.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Cergol, Katie M., Jensen, Paul, Turner, Peter, Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Chemical Communications (Cambridge, United Kingdom) 2007, 1363-1365
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/cergol2007a/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/liu2007/" itemprop="url">Trishomocubanes: Novel σ ligands modulate cocaine-induced behavioral effects.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        Trishomocubane analogs TC1 (I) and TC4 (II) were evaluated for their modulatory effects on locomotor activity as well as interactions with cocaine-induced responses.  TC1 and TC4 have high affinity and moderate to high selectivity for σ1 (Ki = 10 nM, σ1/σ2 = 0.03) and σ2 (Ki = 20 nM, σ1/σ2 = 7.6) receptor subtypes resp.  Both compds. have negligible affinity for the dopamine (DAT), serotonin (SERT), and norepinephrine (NET) transporters.  In behavioral studies, TC1 produced a dose-related inhibition in spontaneous locomotor activity measured in a Digiscan app.  TC1 attenuated the stimulatory locomotor effect of 20 mg/kg cocaine with a half-maximal depressant activity (ID50) of 38.6 mg/kg.  TC1 (dose range of 25 to 100 mg/kg) also partially substituted for the effect of cocaine (10 mg/kg) in a discriminative stimulus task, involving the trained discrimination between cocaine and saline using a two-lever choice method.  Following a dose of 50 mg/kg TC1, a max. of 31% substitution was reached.  The response rate was reduced to 56% of vehicle control following a TC1 dose of 100 mg/kg.  These behavioral effects suggest that TC1 can act as an antagonist via the σ1 receptor.  In contrast to TC1, TC4 produced a stimulant effect in locomotor activity with the ED50 estd. at 0.94 mg/kg.  In addn., TC4 failed to inhibit cocaine-induced stimulation; neither did it substitute for the discriminative stimulus effects of cocaine.  TC4 thus appears to interact predominantly with the σ2 receptor subtype (σ1/σ2 = 7.6) which may result in dopamine stimulation independent of the effects of cocaine.  The differential effect of TC1 and TC4 warrants further study of the mechanism of these actions.  Present data also suggests a potential role for trishomocubane analogs in developing medication or research tools for cocaine addiction.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Liu, Xiang, Banister, Samuel D., Christie, MacDonald J., Banati, Richard, Meikle, Steve, Coster, Mark J., Kassiou, Michael.
        
      </div>

      <div class="pub-publication">
        
        European Journal of Pharmacology 2007, 555, 37-42
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/liu2007/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/issa2006/" itemprop="url">Regioselective Reduction of 3-Methoxymaleimides: An Efficient Method for the Synthesis of Methyl 5-Hydroxytetramates.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        3-Methoxymaleimide and various N-alkyl-3-methoxymaleimides, synthesized by base-promoted N-alkylation of 3-methoxymaleimide, were reduced using sodium borohydride with complete regioselectivity.  The resultant Me 5-hydroxytetramates I (R = H, Me, Et, CH2CH:CH, Ph, CH2Ph, CH2C6H4-4-OMe) are useful intermediates in the synthesis of a variety of tetramate derivs.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Issa, Fatiah, Fischer, Joshua, Turner, Peter, Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Journal of Organic Chemistry 2006, 71, 4703-4705
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/issa2006/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/cergol2005/" itemprop="url">The boron-mediated ketone-ketone aldol reaction.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The first examples of the directed, boron-mediated aldol reaction between different ketones are presented.  Transformation of a variety of ketones to their corresponding boron enolates with (chloro)di(cyclohexyl)borane/Et3N, followed by reaction with acceptor ketones in di-Et ether, and oxidn. of the resultant boron aldolate (H2O2, MeOH/pH 7 buffer), provided the aldol addn. products.  The reaction was most facile when cyclic ketones were used, with the highest yields obtained for the reaction of boron enolates with cyclohexanone as the acceptor.  The boron-mediated aldol reaction of 1-(phenylmethyl)-4-piperidinone with cyclohexanone gave 3-(1-hydroxycyclohexyl)-1-(phenylmethyl)-4-piperidinone.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Cergol, Katie M., Turner, Peter, Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Tetrahedron Letters 2005, 46, 1505-1509
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/cergol2005/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/paterson2005/" itemprop="url">The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: fragment couplings, completion of the synthesis, analogue generation and biological evaluation.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The antimitotic marine macrolide altohyrtin A/spongistatin 1 has been synthesized in a highly convergent and stereocontrolled manner, thus contributing to the replenishment of the largely exhausted material from the initial isolation work.  Coupling of the AB- and CD-spiroacetal subunits, I and II, resp., by a stereoselective aldol reaction was achieved by using either a lithium (67:33 dr) or boron enolate (90:10 dr).  A highly (Z)-selective Wittig coupling was used to unite the northern hemisphere aldehyde III with the southern hemisphere phosphonium salt IV.  Deprotection and subsequent regioselective macrolactonization on a triol seco-acid completed the synthesis of altohyrtin A.  Two structural analogs were also prepd. and evaluated as growth inhibitory agents against a range of human tumor cell lines, including Taxol-resistant strains, alongside altohyrtin A and paclitaxel (Taxol), revealing that dehydration in the E-ring is tolerated and results in enhanced cytotoxicity (at the low picomolar level), whereas the presence of the full C44-C51 side-chain appears to be crucial for biol. activity.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Paterson, Ian, Chen, David Y.-K., Coster, Mark J., Acena, Jose L., Bach, Jordi, Wallace, Debra J.
        
      </div>

      <div class="pub-publication">
        
        Organic &amp; Biomolecular Chemistry 2005, 3, 2431-2440
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/paterson2005/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/paterson2005c/" itemprop="url">The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: the AB-spiroacetal segment.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The convergent synthesis of the C1-C15 AB-spiroacetal subunit I of altohyrtin A/spongistatin 1 is described.  This highly stereocontrolled synthesis relies on matched boron aldol reactions of chiral Me ketones, under Ipc2BCl mediation, to establish the C5, C9 and C11 stereocenters, and formation of the desired thermodn. spiroacetal under acidic conditions.  The scalable synthetic sequence developed provided access to multi-gram quantities of I, thus enabling the successful completion of the total synthesis of altohyrtin A/spongistatin, as reported in Part 4.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Paterson, Ian, Coster, Mark J., Chen, David Y.-K., Oballa, Renata M., Wallace, Debra J., Norcross, Roger D.
        
      </div>

      <div class="pub-publication">
        
        Organic &amp; Biomolecular Chemistry 2005, 3, 2399-2409
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/paterson2005c/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/paterson2005b/" itemprop="url">The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: the CD-spiroacetal segment.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        tereocontrolled syntheses of the C16-C28 CD-spiroacetal subunit I of altohyrtin A/spongistatin 1, relying on kinetic and thermodn. control of the spiroacetal formation, are described.  The kinetic control approach resulted in a slight preference (60 : 40) for the desired spiroacetal isomer.  The thermodn. approach allowed ready access to the desired spiroacetal I by acid-promoted equilibration, chromatog. sepn. of the C23 epimers and resubjection of the undesired isomer to the equilibration conditions.  This scalable synthetic sequence provided multi-gram quantities of I, thus enabling the successful completion of the total synthesis of altohyrtin A/spongistatin 1, as reported in Part 4 of this series.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Paterson, Ian, Coster, Mark J., Chen, David Y.-K., Gibson, Karl R., Wallace, Debra J.
        
      </div>

      <div class="pub-publication">
        
        Organic &amp; Biomolecular Chemistry 2005, 3, 2410-2419
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/paterson2005b/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/paterson2005a/" itemprop="url">The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: the southern hemisphere EF segment.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The fully functionalized C29-C51 southern hemisphere I·I- of altohyrtin A/spongistatin 1, incorporating the E- and F-ring tetrahydropyran rings and the unsatd. side chain, has been synthesized in a highly convergent and stereocontrolled manner.  Key steps in the synthesis of this phosphonium salt include four highly diastereoselective, substrate-controlled, boron aldol reactions to establish key C-C bonds and accompanying stereocenters, where the introduction of the chlorodiene side chain and the C47 hydroxyl-bearing center were realized by exploiting remote stereoinduction from the F-ring tetrahydropyran.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Paterson, Ian, Coster, Mark J., Chen, David Y.-K., Acena, Jose L., Bach, Jordi, Keown, Linda E., Trieselmann, Thomas.
        
      </div>

      <div class="pub-publication">
        
        Organic &amp; Biomolecular Chemistry 2005, 3, 2420-2430
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/paterson2005a/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/banwell2003/" itemprop="url">A total synthesis of the styryllactone (&#43;)-goniodiol from naphthalene.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The cytotoxic natural product (+)-goniodiol was prepd. in twelve steps from enantiomerically pure cis-dihydrocatechol, which is readily obtained by microbial oxidn. of naphthalene.  Elaboration of the cis-dihydrocatechol involves an initial oxidative cleavage to dialdehyde followed by redn. to give a diol.  Conversion of the diol into an acetal required, inter alia, selective oxidn. of the benzylic alc. moiety followed by a metal-catalyzed decarbonylation of the resulting aldehyde.  Allylation of I with allyltributylstannane in the presence of lithium perchlorate gave a ca. 2.7:1 mixt. of alcs., each of which was converted into the corresponding acrylate under std. conditions.  Subjection of these ester derivs. to a ring-closing metathesis (RCM) reaction with Grubbs&rsquo; first-generation catalyst gave the anticipated lactone II and its diastereomer.  Acid-catalyzed removal of the acetonide protecting group within II then afforded (+)-goniodiol, while analogous deprotection of the congener afforded 6-epi-(+)-goniodiol.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Banwell, Martin G., Coster, Mark J., Edwards, Alison J., Karunaratne, Ochitha P., Smith, Jason A., Welling, Lee L., Willis, Anthony C.
        
      </div>

      <div class="pub-publication">
        
        Australian Journal of Chemistry 2003, 56, 585-595
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/banwell2003/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/banwell2003a/" itemprop="url">CP-225,917 and CP-263,114 synthesis support studies: Testing a radical cyclization strategy for installation of the side-chains.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The selenocarbonate (I) has been prepd. and shown to react with hexabutyldistannane hydride/allyltributylstannane to give, via a radical cyclization/allylation sequence, the lactone (II) embodying vicinal and trans-related functionality likely to be appropriate for elaboration to the side-chains assocd. with the title compds., a.k.a. phomoidride A and phomoidride B, resp.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Banwell, Martin G., Coster, Mark J., Edwards, Alison J., Voegtle, Markus.
        
      </div>

      <div class="pub-publication">
        
        Australian Journal of Chemistry 2003, 56, 577-583
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/banwell2003a/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/banwell2003b/" itemprop="url">Selective Cleavage of N-Benzyl-Protected Secondary Amines by Triphosgene.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        A series of competition expts. has revealed that selective cleavage of N-benzyl-protected secondary amines can be achieved with triphosgene, thereby providing a useful range of carbamoyl chlorides.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Banwell, Martin G., Coster, Mark J., Harvey, Michael J., Moraes, John.
        
      </div>

      <div class="pub-publication">
        
        Journal of Organic Chemistry 2003, 68, 613-616
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/banwell2003b/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/paterson2003/" itemprop="url">Synthesis and biological evaluation of spongistatin/altohyrtin analogues: E-ring dehydration and C46 side-chain truncation.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        mplified analogs of the potent antimitotic marine macrolide spongistatin 1/altohyrtin A were synthesized and evaluated as growth inhibitory agents against a range of human tumor cell lines, including Taxol-resistant strains, revealing that E-ring dehydration leads to enhanced cytotoxicity at the low picomolar level while truncation of the side-chain at C46 results in a drastic decrease in activity.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Paterson, Ian, Acena, Jose L., Bach, Jordi, Chen, David Y.-K., Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Chemical Communications (Cambridge, United Kingdom) 2003, 462-463
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/paterson2003/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/banwell2002/" itemprop="url">A chemoenzymatic synthesis of the styryllactone (&#43;)-goniodiol from naphthalene.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The enantiomerically pure cis-1,2-diol I, which is obtained by microbial oxidn. of naphthalene, has been converted, via a sequence of reactions including oxidative C-C bond cleavage, decarbonylation and ring-closing metathesis steps, into the natural product (+)-goniodiol (II).
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Banwell, Martin G., Coster, Mark J., Karunaratne, Ochitha P., Smith, Jason A.
        
      </div>

      <div class="pub-publication">
        
        Journal of the Chemical Society, Perkin Transactions 1 2002, 1622-1624
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/banwell2002/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/coster2002/" itemprop="url">Medium Ring Ethers by Ring Expansion-Ring Contraction: Synthesis of Lauthisan.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        A new general method for the construction of medium ring ethers has been developed.  This involves the ring expansion of halo-O,S-acetals followed by a Ramberg-Backlund ring contraction reaction with concomitant extrusion of the sulfur atom.  This methodol. has been utilized for the synthesis of racemic cis- and trans-lauthisan (I and II resp.).
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Coster, Mark J., De Voss, James J.
        
      </div>

      <div class="pub-publication">
        
        Organic Letters 2002, 4, 3047-3050
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/coster2002/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/paterson2002/" itemprop="url">Total synthesis of altohyrtin A (spongistatin 1): an alternative synthesis of the CD-spiroacetal subunit.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        The CD-spiroacetal contg. C16-C28 subunit I, as used in the total synthesis of the potent cytotoxic macrolide altohyrtin A (spongistatin 1), was prepd. by an alternative route using substrate-based stereocontrol in the two aldol bond constructions generating the acyclic precursor II.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Paterson, Ian, Coster, Mark J.
        
      </div>

      <div class="pub-publication">
        
        Tetrahedron Letters 2002, 43, 3285-3289
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/paterson2002/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    <div class="pub-list-item" itemscope itemtype="http://schema.org/CreativeWork">
  <div class="row">

    

    <div class="col-md-12">

    

      <h3 class="article-title" itemprop="name">
        <a href="https://mcoster.github.io/publication/paterson2001/" itemprop="url">Stereocontrolled total synthesis of (&#43;)-altohyrtin A/spongistatin 1.</a>
      </h3>

      <div class="pub-abstract" itemprop="text">
        
        An enantioselective total synthesis of spongistatin 1, a.k.a. (+)-altohyrtin A, was achieved via a multistep synthetic sequence which included Wittig olefination, aldol condensation, and macrolactonization.
        
      </div>

      <div class="pub-authors" itemprop="author">
        
        Paterson, Ian, Chen, David Y.-K., Coster, Mark J., Acena, Jose L., Bach, Jordi, Gibson, Karl R., Keown, Linda E., Oballa, Renata M., Trieselmann, Thomas, Wallace, Debra J., Hodgson, Andrew P., Norcross, Roger D.
        
      </div>

      <div class="pub-publication">
        
        Angewandte Chemie, International Edition 2001, 40, 4055-4060
        
      </div>

      <div class="pub-links">
        



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/paterson2001/">
  Details
</a>









      </div>

    </div>
  </div>
</div>

    
    

  </div>
</div>

    </div>
  </section>

  
  
  <section id="publications" class="home-section">
    <div class="container">
      




<div class="row">
  <div class="col-xs-12 col-md-4 section-heading">
    <h1>Recent Publications</h1>
    
    
    <p class="view-all">
      <a href="/publication/">
        More Publications
        <i class="fa fa-angle-double-right"></i>
      </a>
    </p>
    
  </div>
  <div class="col-xs-12 col-md-8">
    

    
    <ul class="fa-ul">
      
      <li itemscope itemtype="http://schema.org/CreativeWork">
  <i class="fa-li fa fa-file-text-o pub-icon" aria-hidden="true"></i>
  <span itemprop="name">A bidirectional synthesis of spiroacetals via Rh(II)-catalysed C-H insertion.</span>
  <p>



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/lepage2017/">
  Details
</a>








</p>
</li>

      
      <li itemscope itemtype="http://schema.org/CreativeWork">
  <i class="fa-li fa fa-file-text-o pub-icon" aria-hidden="true"></i>
  <span itemprop="name">Enzyme characteristics of pathogen-specific trehalose-6-phosphate phosphatases</span>
  <p>



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/cross2017a/">
  Details
</a>








</p>
</li>

      
      <li itemscope itemtype="http://schema.org/CreativeWork">
  <i class="fa-li fa fa-file-text-o pub-icon" aria-hidden="true"></i>
  <span itemprop="name">Probing function and structure of trehalose-6-phosphate phosphatases from pathogenic organisms suggests distinct molecular groupings.</span>
  <p>



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/cross2017/">
  Details
</a>








</p>
</li>

      
      <li itemscope itemtype="http://schema.org/CreativeWork">
  <i class="fa-li fa fa-file-text-o pub-icon" aria-hidden="true"></i>
  <span itemprop="name">The design, synthesis, and anti-inflammatory evaluation of a drug-like library based on the natural product valerenic acid.</span>
  <p>



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/egbewande2017/">
  Details
</a>








</p>
</li>

      
      <li itemscope itemtype="http://schema.org/CreativeWork">
  <i class="fa-li fa fa-file-text-o pub-icon" aria-hidden="true"></i>
  <span itemprop="name">Panel docking of small-molecule libraries - Prospects to improve efficiency of lead compound discovery.</span>
  <p>



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/sarnpitak2015/">
  Details
</a>








</p>
</li>

      
      <li itemscope itemtype="http://schema.org/CreativeWork">
  <i class="fa-li fa fa-file-text-o pub-icon" aria-hidden="true"></i>
  <span itemprop="name">Rhodium(II)-catalyzed intramolecular C-H insertion α- to oxygen: reactivity, selectivity and applications to natural product synthesis.</span>
  <p>



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/lombard2015/">
  Details
</a>








</p>
</li>

      
      <li itemscope itemtype="http://schema.org/CreativeWork">
  <i class="fa-li fa fa-file-text-o pub-icon" aria-hidden="true"></i>
  <span itemprop="name">Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold.</span>
  <p>



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/schwartz2015a/">
  Details
</a>








</p>
</li>

      
      <li itemscope itemtype="http://schema.org/CreativeWork">
  <i class="fa-li fa fa-file-text-o pub-icon" aria-hidden="true"></i>
  <span itemprop="name">Synthesis and antiplasmodial evaluation of analogues based on the tricyclic core of Thiaplakortones A-D.</span>
  <p>



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/schwartz2015/">
  Details
</a>








</p>
</li>

      
      <li itemscope itemtype="http://schema.org/CreativeWork">
  <i class="fa-li fa fa-file-text-o pub-icon" aria-hidden="true"></i>
  <span itemprop="name">Synthesis of N-alkylsulfonamides by borane-dimethyl sulfide reduction of N-acylsulfonamides.</span>
  <p>



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/james2015/">
  Details
</a>








</p>
</li>

      
      <li itemscope itemtype="http://schema.org/CreativeWork">
  <i class="fa-li fa fa-file-text-o pub-icon" aria-hidden="true"></i>
  <span itemprop="name">Total Synthesis of Thiaplakortone A: Derivatives as Metabolically Stable Leads for the Treatment of Malaria.</span>
  <p>



<a class="btn btn-primary btn-outline btn-xs" href="https://mcoster.github.io/publication/pouwer2014/">
  Details
</a>








</p>
</li>

      
    </ul>
    

  </div>
</div>

    </div>
  </section>

  
  
  <section id="talks" class="home-section">
    <div class="container">
      




<div class="row">
  <div class="col-xs-12 col-md-4 section-heading">
    <h1>Recent &amp; Upcoming Talks</h1>
    
    
  </div>
  <div class="col-xs-12 col-md-8">
    

    
    <ul class="fa-ul">
      
      <li itemscope itemtype="http://schema.org/CreativeWork">
  <i class="fa-li fa fa-comment-o pub-icon" aria-hidden="true"></i>
  <span itemprop="name"><a href="https://mcoster.github.io/talk/example-talk/">Example Talk</a></span>
  <p>
    2017,
    
            Hugo Academic Theme Conference
    
  </p>
</li>

      
    </ul>
    

  </div>
</div>

    </div>
  </section>

  
  
  <section id="posts" class="home-section">
    <div class="container">
      




<div class="row">
  <div class="col-xs-12 col-md-4 section-heading">

    <h1>Recent Posts</h1>
    
    

  </div>
  <div class="col-xs-12 col-md-8">

    

    
      
        
        


<div class="article-list-item" itemscope itemprop="blogPost">
  
  
  <a href="https://mcoster.github.io/post/getting-started/">
    <img src="/img/headers/getting-started.png" class="article-banner" itemprop="image">
  </a>
  
  <h3 class="article-title" itemprop="name">
    <a href="https://mcoster.github.io/post/getting-started/" itemprop="url">Getting started with the Academic framework for Hugo</a>
  </h3>
  

<div class="article-metadata">

  <span class="article-date">
    <time datetime="2016-04-20 12:00:00 &#43;0000 UTC" itemprop="datePublished">
      2016
    </time>
  </span>

  

  
  
  
  <span class="article-tags">
    <i class="fa fa-tags"></i>
    
    <a href="/tags/academic">academic</a
    >, 
    
    <a href="/tags/hugo">hugo</a
    >
    
  </span>
  
  

  

</div>

  <div class="article-style" itemprop="articleBody">
    
    <p>Create a beautifully simple personal or academic website in under 10 minutes.</p>
    
  </div>
  <p class="read-more">
    <a href="https://mcoster.github.io/post/getting-started/" class="btn btn-primary btn-outline">
      CONTINUE READING
    </a>
  </p>
</div>

      
        
        


<div class="article-list-item" itemscope itemprop="blogPost">
  
  
  <h3 class="article-title" itemprop="name">
    <a href="https://mcoster.github.io/post/widgets/" itemprop="url">Customizing the homepage with widgets</a>
  </h3>
  

<div class="article-metadata">

  <span class="article-date">
    <time datetime="2016-04-20 11:00:00 &#43;0000 UTC" itemprop="datePublished">
      2016
    </time>
  </span>

  

  
  
  
  <span class="article-tags">
    <i class="fa fa-tags"></i>
    
    <a href="/tags/academic">academic</a
    >, 
    
    <a href="/tags/hugo">hugo</a
    >
    
  </span>
  
  

  

</div>

  <div class="article-style" itemprop="articleBody">
    
    <p>Enable/disable and configure widgets to customize your homepage.</p>
    
  </div>
  <p class="read-more">
    <a href="https://mcoster.github.io/post/widgets/" class="btn btn-primary btn-outline">
      CONTINUE READING
    </a>
  </p>
</div>

      
        
        


<div class="article-list-item" itemscope itemprop="blogPost">
  
  
  <h3 class="article-title" itemprop="name">
    <a href="https://mcoster.github.io/post/managing-content/" itemprop="url">Managing content</a>
  </h3>
  

<div class="article-metadata">

  <span class="article-date">
    <time datetime="2016-04-20 11:00:00 &#43;0000 UTC" itemprop="datePublished">
      2016
    </time>
  </span>

  

  
  
  
  <span class="article-tags">
    <i class="fa fa-tags"></i>
    
    <a href="/tags/academic">academic</a
    >, 
    
    <a href="/tags/hugo">hugo</a
    >
    
  </span>
  
  

  

</div>

  <div class="article-style" itemprop="articleBody">
    
    <p>This is a brief guide to managing content with the Academic framework. Content can include publications, projects, talks, and news/blog articles. After you have read this guide about creating and managing content, you may also be interested to learn about <a href="https://mcoster.github.io/post/writing-markdown-latex/" target="_blank">writing content with Markdown, LaTeX, and Shortcodes</a>.</p>
    
  </div>
  <p class="read-more">
    <a href="https://mcoster.github.io/post/managing-content/" class="btn btn-primary btn-outline">
      CONTINUE READING
    </a>
  </p>
</div>

      
        
        


<div class="article-list-item" itemscope itemprop="blogPost">
  
  
  <h3 class="article-title" itemprop="name">
    <a href="https://mcoster.github.io/post/writing-markdown-latex/" itemprop="url">Writing content with Markdown, LaTeX, and Shortcodes</a>
  </h3>
  

<div class="article-metadata">

  <span class="article-date">
    <time datetime="2016-04-20 10:00:00 &#43;0000 UTC" itemprop="datePublished">
      2016
    </time>
  </span>

  

  
  
  
  

  

</div>

  <div class="article-style" itemprop="articleBody">
    
    <p>Content can be written using <a href="https://github.com/adam-p/markdown-here/wiki/Markdown-Cheatsheet" target="_blank">Markdown</a>, <a href="https://en.wikibooks.org/wiki/LaTeX/Mathematics" target="_blank">LaTeX math</a>, and <a href="http://gohugo.io/extras/shortcodes/" target="_blank">Hugo Shortcodes</a>. Additionally, HTML may be used for advanced formatting. This article gives an overview of the most common formatting options.</p>
    
  </div>
  <p class="read-more">
    <a href="https://mcoster.github.io/post/writing-markdown-latex/" class="btn btn-primary btn-outline">
      CONTINUE READING
    </a>
  </p>
</div>

      
        
        


<div class="article-list-item" itemscope itemprop="blogPost">
  
  
  <h3 class="article-title" itemprop="name">
    <a href="https://mcoster.github.io/post/migrate-from-jekyll/" itemprop="url">Migrate from Jekyll to Hugo</a>
  </h3>
  

<div class="article-metadata">

  <span class="article-date">
    <time datetime="2014-03-10 00:00:00 &#43;0000 UTC" itemprop="datePublished">
      2014
    </time>
  </span>

  

  
  
  
  <span class="article-tags">
    <i class="fa fa-tags"></i>
    
    <a href="/tags/jekyll">jekyll</a
    >
    
  </span>
  
  

  

</div>

  <div class="article-style" itemprop="articleBody">
    
    <p>Learn how to migrate an existing website from Jekyll to Hugo.</p>
    
  </div>
  <p class="read-more">
    <a href="https://mcoster.github.io/post/migrate-from-jekyll/" class="btn btn-primary btn-outline">
      CONTINUE READING
    </a>
  </p>
</div>

      
    

  </div>
</div>

    </div>
  </section>

  
  
  <section id="projects" class="home-section">
    <div class="container">
      



<div class="row">
  <div class="col-xs-12 col-md-4 section-heading">
    <h1>Projects</h1>
    
  </div>
  <div class="col-xs-12 col-md-8">
    

    <div class="project-toolbar">
      <div id="filters">
        <div class="btn-toolbar">
          <div class="btn-group">
          
            <a href="#" data-filter="*" class="btn btn-primary btn-large active">All</a>
          
            <a href="#" data-filter=".deep-learning" class="btn btn-primary btn-large">Deep Learning</a>
          
            <a href="#" data-filter=".demo" class="btn btn-primary btn-large">Other</a>
          
          </div>
        </div>
      </div>
    </div>

    

    <div id="container-projects" class="row isotope">

      
      
      
      
      
      
      
      <div class="col-xs-12 col-sm-6 col-md-4 col-lg-6 project-item isotope-item malaria med-chem">
        <div class="card">
          
          <a href="http://opensourcemalaria.org/" title="" class="card-image hover-overlay"
             target="_blank">
            <img src="/img/Malaria_Scheme.png" alt="" class="img-responsive">
          </a>
          
          <div class="card-text">
            <h4><a href="http://opensourcemalaria.org/" target="_blank">Open Source Malaria</a></h4>
            <div class="card-desription">
              <p>We work with researchers worldwide on the Open Source Malaria project.</p>
            </div>
          </div>
        </div>
      </div>
      
      
      
      
      <div class="col-xs-12 col-sm-6 col-md-4 col-lg-6 project-item isotope-item deep-learning">
        <div class="card">
          
          <a href="https://mcoster.github.io/project/deep-learning/" title="" class="card-image hover-overlay"
             >
            <img src="/img/bubbles.jpg" alt="" class="img-responsive">
          </a>
          
          <div class="card-text">
            <h4><a href="https://mcoster.github.io/project/deep-learning/" >Deep Learning</a></h4>
            <div class="card-desription">
              <p>Lorem ipsum dolor sit amet, consectetur adipiscing elit.</p>
            </div>
          </div>
        </div>
      </div>
      

    </div>

    

  </div>
</div>

    </div>
  </section>

  
  
  <section id="teaching" class="home-section">
    <div class="container">
      


<div class="row">
  <div class="col-xs-12 col-md-4 section-heading">
    <h1>Teaching</h1>
    
  </div>
  <div class="col-xs-12 col-md-8">
    <p>I teach the following courses at Griffith University:</p>

<ul>
<li>3105NSC: Advanced Organic Chemistry (<em>Convenor</em>)</li>
<li>3104NSC: Drug Design and Delivery</li>
<li>6103NSC: Advanced Synthetic Chemistry (<em>Convenor</em>)</li>
</ul>

  </div>
</div>

    </div>
  </section>

  
  
  <section id="contact" class="home-section">
    <div class="container">
      




<div class="row">
  <div class="col-xs-12 col-md-4 section-heading">
    <h1>Contact</h1>
    
  </div>
  <div class="col-xs-12 col-md-8">
    

    <ul class="fa-ul" itemscope>

      
      <li>
        <i class="fa-li fa fa-envelope fa-2x" aria-hidden="true"></i>
        <span id="person-email" itemprop="email"><a href="mailto:m.coster@griffith.edu.au">m.coster@griffith.edu.au</a></span>
      </li>
      

      

      
      <li>
        <i class="fa-li fa fa-phone fa-2x" aria-hidden="true"></i>
        <span id="person-telephone" itemprop="telephone"><a href="tel:&#43;61-7-3735-6037">&#43;61-7-3735-6037</a></span>
      </li>
      

      

      

      
      <li>
        <i class="fa-li fa fa-map-marker fa-2x" aria-hidden="true"></i>
        <span id="person-address" itemprop="address">Griffith Institute for Drug Discovery (GRIDD), Griffith University, Brisbane, Queensland 4111, Australia</span>
      </li>
      

      
      <li>
        <i class="fa-li fa fa-clock-o fa-2x" aria-hidden="true"></i>
        <span>Email for appointment</span>
      </li>
      

    </ul>

  </div>
</div>

    </div>
  </section>



<footer class="site-footer">
  <div class="container">
    <p class="powered-by">

      &copy; 2017 Mark Coster &middot; 

      Powered by the <a href="https://github.com/gcushen/hugo-academic" target="_blank">Academic
      theme</a> for <a href="http://gohugo.io" target="_blank">Hugo</a>.

      <span class="pull-right" aria-hidden="true">
        <a href="#" id="back_to_top">
          <span class="button_icon">
            <i class="fa fa-chevron-up fa-2x"></i>
          </span>
        </a>
      </span>

    </p>
  </div>
</footer>

    
    <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/1.12.4/jquery.min.js" integrity="sha512-jGsMH83oKe9asCpkOVkBnUrDDTp8wl+adkB2D+//JtlxO4SrLoJdhbOysIFQJloQFD+C4Fl1rMsQZF76JjV0eQ==" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.2/imagesloaded.pkgd.min.js" integrity="sha512-iHzEu7GbSc705hE2skyH6/AlTpOfBmkx7nUqTLGzPYR+C1tRaItbRlJ7hT/D3YQ9SV0fqLKzp4XY9wKulTBGTw==" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/gsap/1.19.1/TweenMax.min.js" integrity="sha512-Z5heTz36xTemt1TbtbfXtTq5lMfYnOkXM2/eWcTTiLU01+Sw4ku1i7vScDc8fWhrP2abz9GQzgKH5NGBLoYlAw==" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/gsap/1.19.1/plugins/ScrollToPlugin.min.js" integrity="sha512-CDeU7pRtkPX6XJtF/gcFWlEwyaX7mcAp5sO3VIu/ylsdR74wEw4wmBpD5yYTrmMAiAboi9thyBUr1vXRPA7t0Q==" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha512-iztkobsvnjKfAtTNdHkGVjAYTrrtlC7mGp/54c40wowO7LhURYl3gVzzcEqGl/qKXQltJ2HwMrdLcNUdo+N/RQ==" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.4/isotope.pkgd.min.js" integrity="sha512-VDBOIlDbuC4VWxGJNmuFRQ0Li0SKkDpmGyuhAG5LTDLd/dJ/S0WMVxriR2Y+CyPL5gzjpN4f/6iqWVBJlht0tQ==" crossorigin="anonymous"></script>
    
    <script src="/js/hugo-academic.js"></script>
    

    
    
      
      <script src="//cdnjs.cloudflare.com/ajax/libs/highlight.js/9.9.0/highlight.min.js"></script>

      

      

      <script>hljs.initHighlightingOnLoad();</script>
    

    
    

  </body>
</html>

